395 related articles for article (PubMed ID: 30385175)
1. The role of placental growth factor (PlGF) and its receptor system in retinal vascular diseases.
Van Bergen T; Etienne I; Cunningham F; Moons L; Schlingemann RO; Feyen JHM; Stitt AW
Prog Retin Eye Res; 2019 Mar; 69():116-136. PubMed ID: 30385175
[TBL] [Abstract][Full Text] [Related]
2. Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases.
Nguyen QD; De Falco S; Behar-Cohen F; Lam WC; Li X; Reichhart N; Ricci F; Pluim J; Li WW
Acta Ophthalmol; 2018 Feb; 96(1):e1-e9. PubMed ID: 27874278
[TBL] [Abstract][Full Text] [Related]
3. Neutralization of placental growth factor as a novel treatment option in diabetic retinopathy.
Van Bergen T; Hu TT; Etienne I; Reyns GE; Moons L; Feyen JHM
Exp Eye Res; 2017 Dec; 165():136-150. PubMed ID: 28965804
[TBL] [Abstract][Full Text] [Related]
4. Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization.
Rakic JM; Lambert V; Devy L; Luttun A; Carmeliet P; Claes C; Nguyen L; Foidart JM; Noël A; Munaut C
Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3186-93. PubMed ID: 12824270
[TBL] [Abstract][Full Text] [Related]
5. The Placental Growth Factor Pathway and Its Potential Role in Macular Degenerative Disease.
Cunningham F; Van Bergen T; Canning P; Lengyel I; Feyen JHM; Stitt AW
Curr Eye Res; 2019 Aug; 44(8):813-822. PubMed ID: 31055948
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of ocular neovascularization by co-inhibition of VEGF-A and PLGF.
Huo X; Li Y; Jiang Y; Sun X; Gu L; Guo W; Sun D
Cell Physiol Biochem; 2015; 35(5):1787-96. PubMed ID: 25832861
[TBL] [Abstract][Full Text] [Related]
7. Co-inhibition of PGF and VEGF blocks their expression in mononuclear phagocytes and limits neovascularization and leakage in the murine retina.
Balser C; Wolf A; Herb M; Langmann T
J Neuroinflammation; 2019 Feb; 16(1):26. PubMed ID: 30732627
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Placenta Growth Factor Reduces Subretinal Mononuclear Phagocyte Accumulation in Choroidal Neovascularization.
Crespo-Garcia S; Corkhill C; Roubeix C; Davids AM; Kociok N; Strauss O; Joussen AM; Reichhart N
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):4997-5006. PubMed ID: 28979997
[TBL] [Abstract][Full Text] [Related]
9. [Placenta Growth Factor (PlGF) and Retinal Vascular Diseases--Current Knowledge from Experimental and Clinical Studies].
Augustin AJ
Klin Monbl Augenheilkd; 2016 Jan; 233(1):57-65. PubMed ID: 26797889
[TBL] [Abstract][Full Text] [Related]
10. VEGF but not PlGF disturbs the barrier of retinal endothelial cells.
Deissler HL; Deissler H; Lang GK; Lang GE
Exp Eye Res; 2013 Oct; 115():162-71. PubMed ID: 23891860
[TBL] [Abstract][Full Text] [Related]
11. BI-Y, an Neuropilin-1 Antagonist, Enhances Revascularization and Prevents Vascular Endothelial Growth Factor-A Induced Retinal Hyperpermeability in Rodent Models of Retinopathies.
Thomas L; Low S; Hansen G; Bakker RA; Zippel N
J Pharmacol Exp Ther; 2023 Jun; 385(3):214-221. PubMed ID: 36997325
[TBL] [Abstract][Full Text] [Related]
12. Deletion of placental growth factor prevents diabetic retinopathy and is associated with Akt activation and HIF1α-VEGF pathway inhibition.
Huang H; He J; Johnson D; Wei Y; Liu Y; Wang S; Lutty GA; Duh EJ; Semba RD
Diabetes; 2015 Jan; 64(1):200-12. PubMed ID: 25187372
[TBL] [Abstract][Full Text] [Related]
13. Vitreous levels of placental growth factor correlate with activity of proliferative diabetic retinopathy and are not influenced by bevacizumab treatment.
Al Kahtani E; Xu Z; Al Rashaed S; Wu L; Mahale A; Tian J; Abboud EB; Ghazi NG; Kozak I; Gupta V; Arevalo JF; Duh EJ
Eye (Lond); 2017 Apr; 31(4):529-536. PubMed ID: 27886182
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.
Aiello LP; Avery RL; Arrigg PG; Keyt BA; Jampel HD; Shah ST; Pasquale LR; Thieme H; Iwamoto MA; Park JE
N Engl J Med; 1994 Dec; 331(22):1480-7. PubMed ID: 7526212
[TBL] [Abstract][Full Text] [Related]
15. [Aging and retinal vascular diseases].
Takagi H
Nippon Ganka Gakkai Zasshi; 2007 Mar; 111(3):207-30; discussion 231. PubMed ID: 17402563
[TBL] [Abstract][Full Text] [Related]
16. Both Autocrine Signaling and Paracrine Signaling of HB-EGF Enhance Ocular Neovascularization.
Inoue Y; Shimazawa M; Nakamura S; Takata S; Hashimoto Y; Izawa H; Masuda T; Tsuruma K; Sakaue T; Nakayama H; Higashiyama S; Hara H
Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):174-185. PubMed ID: 29191924
[TBL] [Abstract][Full Text] [Related]
17. Molecular pathogenesis of retinal and choroidal vascular diseases.
Campochiaro PA
Prog Retin Eye Res; 2015 Nov; 49():67-81. PubMed ID: 26113211
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy.
Amin RH; Frank RN; Kennedy A; Eliott D; Puklin JE; Abrams GW
Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):36-47. PubMed ID: 9008628
[TBL] [Abstract][Full Text] [Related]
19. Role of the vascular endothelial growth factor isoforms in retinal angiogenesis and DiGeorge syndrome.
Stalmans I
Verh K Acad Geneeskd Belg; 2005; 67(4):229-76. PubMed ID: 16334858
[TBL] [Abstract][Full Text] [Related]
20. Osmotic induction of placental growth factor in retinal pigment epithelial cells in vitro: contribution of NFAT5 activity.
Hollborn M; Reichmuth K; Prager P; Wiedemann P; Bringmann A; Kohen L
Mol Biol Rep; 2016 Aug; 43(8):803-14. PubMed ID: 27230578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
